Assays for the detection of anti-TNF drugs and autoantibodies
US9506920B2 · kind B2 · utility
5Cited by
19References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 21, 2014 |
| Grant date | Nov 29, 2016 |
| Priority date | — |
| Expiry date | Sep 22, 2034 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention provides assays for detecting and measuring the presence or level of anti-TNFα drug therapeutics and autoantibodies in a sample. The present invention is useful for optimizing therapy and monitoring patients receiving anti-TNFα drug therapeutics to detect the presence or level of autoantibodies (e.g., HACA and/or HAHA) against the drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.